Delivery Order SPE2DB22D3009-SPE2DB24FBA18

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,142.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Tretinoin 0.025% Cream, a topical medication, with a completion date of February 21, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.40 firm fixed-price delivery order is for the supply of Tretinoin 0.05% gel, a topical retinoid medication. The award has an ultimate completion date of December 9, 2024 and was issued on December 6, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,240.23 firm-fixed-price delivery order is for the supply of Tretinoin 0.025% Cream, a pharmaceutical product, with a period of performance through April 26, 2024. The award was made without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB20D7066|SPE2DB25FC3AZ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,169.44 firm fixed-price delivery order is for the supply of Tretinoin 0.1% Cream, 45 grams. The contract has an ultimate completion date of April 17, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award, SPE2DB20D3505|SPE2DB24FT4Y2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,483.93 firm fixed-price delivery order is for the supply of 45 gram tubes of 0.05% Tretinoin cream, a topical medication. The contract has an ultimate completion date of December 20, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,501.13 firm fixed price delivery order is for the supply of Tretinoin 0.025% Cream, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,653.49 issued under the Defense Logistics Agency's (DLA) Indefinite Delivery Contract (IDC) SPE2DB25FMAUA. The contract is for the supply of Tretinoin 0.05% Cream, a pharmaceutical product used in various medical treatments. The award has an ultimate completion date of October 18, 2024 and is a Firm Fixed Price contract. No set-aside designation was used for this award. As a major pharmaceutical...
This federal contract award, valued at $1,284.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, is for the supply of Tretinoin 0.025% Cream, a dermatological medication. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,510.02, is for the delivery of TRETINOIN 0.1% CREAM 45GM, a topical medication. The contract is a Firm Fixed Price Delivery Order with a completion date of June 13, 2024. No set-aside designation was used for this award. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tretinoin 0.05% Cream in 45 gram units, with a firm fixed price of $1,007.37 and a completion date of September 10, 2024. The contract is a Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB24FBA18
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,199.44 firm fixed-price delivery order is for the supply of Tretinoin 0.05% Cream, 45GM, with a completion date of July 10, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award was not designated with any set-aside requirements.

Generated 5/17/25, 10:15 AM